Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,963 public trials 2,020 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies

NCT07239323

Conditions: B Cell Non-Hodgkin's Lymphoma, B-Acute Lymphoblastic Leukemia, Blood Protein Disorders, +25 more
Locations: 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China Kunming, Yunnan, China

View Trial Details

Recruiting

Clinical Study of Cord Blood-derived IL-10/IL-15 CD19-CAR NK in the Treatment of Refractory/Relapsed B-cell NHL

NCT06707259

Conditions: B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: the Second Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Registry for Adults With Plasma Cell Disorders (PCD's)

NCT03717844

Conditions: Abnormalities, Multiple, Amyloidosis, Blood Protein Disorders, +40 more
Locations: North Carolina Cancer Hospital Chapel Hill, North Carolina, United States

View Trial Details

Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

NCT04094610

Conditions: Astrocytoma, Glioblastoma, Glioma, +30 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

University of California at Los Angeles Los Angeles, California, United States

Children's Hospital Colorado - Anschutz Medical Campus Aurora, Colorado, United States

Local Institution - 2105 Orlando, Florida, United States

View all 68 locations

View Trial Details

Recruiting

A Cohort Study in Newly Diagnosed MZL

NCT06449885

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma

NCT07233720

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university Zhengzhou, Henan, China

View Trial Details

Recruiting

Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia

NCT06530576

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Metabolic and Immunomic Differential Analysis of Primary Central Nervous System Diffuse Large B-Cell Lymphoma

NCT07188077

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China

View Trial Details

Recruiting

Tumor Molecular Profiling in Early Phase Clinical Trials

NCT04510766

Conditions: Advanced Solid Tumor, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations: Oncology Institute of Southern Switzerland Bellinzona, Switzerland

View Trial Details

Recruiting

Quantitative and Qualitative Monocytes Analysis and Their Impact on CART Cells Reponse in Multiple Myeloma

NCT07180992

Conditions: Blood Protein Disorders, CART Cells, Cardiovascular Diseases, +14 more
Locations: CHRU Amiens Amiens, France

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions